# Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus

> **NCT02576366** · PHASE4 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 24 (actual)

## Conditions studied

- Drug Interactions
- Kidney Transplantation

## Interventions

- **DRUG:** Voriconazole
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT02576366
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-05
- **Final completion:** 2017-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02576366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02576366, "Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02576366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*